The LipiDiDiet trial: what does it add to the current evidence for Fortasyn Connect in early Alzheimer’s disease?
Jill Rasmussen1,2 1Primary Care Specialist Mental Health in Dementia and Learning Disability, Surrey, UK; 2Royal College of General Practitioners Representative for Dementia, London, UKAbstract: Nutritional factors can influence the risk of developing Alzheimer’s disease (AD) and its rate...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2019
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/21eccdecb05d434fbbd637380d5134db |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|